Stem cell transplantation for nervous system disorders in Italy, European Union, and Ukraine: Clinical approach and governmental policies

doi:10.18679/CN11-6030/R.2015.016

Translational Neuroscience and Clinics

2015, Vol. 1

Issue (2): 125-127 doi: 10.18679/CN11-6030/R.2015.016

Policies and Regulations

Stem cell transplantation for nervous system disorders in Italy, European Union, and Ukraine: Clinical approach and governmental policies

Dario Siniscalco¹, Nataliia Sych²

1 Department of Experimental Medicine, Second University of Naples, Napoli 80138, Italy;
2 Clinical Department, Cell Therapy Center EmCell, Kiev 04073, Ukraine

Download:

PDF (1702 KB)
Export: BibTeX | EndNote (RIS)

Abstract Several debates have been raised over the use of stem cells in the field of regenerative medicine. Indeed, stem cell transplantation must follow strict rules. However, to date, many differences exist among different Western and Eastern European countries. This brief review summarizes the state-of-the-art stem cell regulation in Italy, European Union, and Ukraine.

Key words： stem cells regulation cell transplantation clinical trial

Received: 08 November 2015 Published: 15 December 2015

Corresponding Authors: Dario Siniscalco, E-mail:dariosin@uab.edu E-mail: dariosin@uab.edu


	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Dario Siniscalco
	Nataliia Sych

Cite this article:

Dario Siniscalco, Nataliia Sych. Stem cell transplantation for nervous system disorders in Italy, European Union, and Ukraine: Clinical approach and governmental policies. Translational Neuroscience and Clinics, 2015, 1(2): 125-127.

URL:

http://tnc.tsinghuajournals.com/10.18679/CN11-6030/R.2015.016 OR http://tnc.tsinghuajournals.com/Y2015/V1/I2/125

[1] http://www.camera.it/parlam/leggi/04040L.htm
[2] http://www.eurostemcell.org/regulations/regulation-stemcell-research-italy
[3] http://leg16.camera.it/561?appro=286
[4] Siniscalco D. Suspended life-Stem cells:Are treatments possible? J Regen Med 2012, 2:1.
[5] http://www.agenziafarmaco.gov.it/it/content/normativa-diriferimento-sperimentazione-clinica
[6] Abbott A. Leaked files slam stem-cell therapy. Nature News 2014, 505:139-140.
[7] http://www.normattiva.it/uri-res/N2Ls?urn:nir:stato:decreto.legge:2013-03-25;24!vig=
[8] http://www.normattiva.it/uri-res/N2Ls?urn:nir:stato:legge:2013-05-23;57
[9] http://www.corriere.it/cronache/14_ottobre_02/staminacomitato-esperti-boccia-metodo-no-sperimentazione-84afe122-4a74-11e4-9fe4-a545a65e6beb.shtml
[10] http://ec.europa.eu/health/human-use/clinical-trials/regulation/index_en.htm#ct1
[11] http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:102:0048:0058:en:PDF
[12] http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:L:2015:093:FULL&from=EN#page=58
[13] Elstner A, Damaschun A, Kurtz A, Stacey G, Arán B, Veiga A, Borstlap J. The changing landscape of European and international regulation on embryonic stem cell research. Stem Cell Res 2009, 2(2):101-107.
[14] http://search.ligazakon.ua/l_doc2.nsf/link1/RE20973.html

[1]	Shasha Dong Na Liu Yang Hu, Ping Zhang, Chao Pan, Youping Zhang, Yingxin Tang, Zhouping Tang. Transplantation of neural progenitor cells differentiated from adipose tissue-derived stem cells for treatment of sciatic nerve injury[J]. Translational Neuroscience and Clinics, 2016, 2(2): 108-119.

[2]	Liyan Qiao, Hongyun Huang, Lin Chen. Cell-based therapy in Alzheimer's disease: Current knowledge and perspective[J]. Translational Neuroscience and Clinics, 2016, 2(1): 50-58.

[3]	Wei Wang, Hao Song, Aifang Shen, Chao Chen, Yanming Liu, Yabing Dong, Fabin Han. Differentiated cells derived from fetal neural stem cells improve motor deficits in a rat model of Parkinson's disease[J]. Translational Neuroscience and Clinics, 2015, 1(2): 75-85.

[4]	He Zhu, Yuanqing Tan, Qi Gu, Weifang Han, Zhongwen Li, Jason S. Meyer, Baoyang Hu. Regulations in the United States for cell transplantation clinical trials in neurological diseases[J]. Translational Neuroscience and Clinics, 2015, 1(2): 114-124.

[5]	Nataliia S. Sych, Olena V. Ivankova, Mariya O. Klunnyk, Iryna G. Matiyashchuk, Andrey A. Sinelnyk, Mariya P. Demchyk, Maryna V. Skalozyb, Dario Siniscalco. Fetal stem cells are effective in the treatment of Grade Ⅰ and Ⅱ respiratory failure in amyotrophic lateral sclerosis and muscular dystrophy[J]. Translational Neuroscience and Clinics, 2015, 1(1): 10-16.

Viewed

Full text

Abstract

Cited

Shared

Discussed